Insider · CIK 0001966926
Eric J Hyllengren
Files at ATRA (Atara Biotherapeutics, Inc.), ZURA (Zura Bio Ltd). First filing Nov 20, 2024, latest Mar 5, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATRA: Atara Biotherapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Atara Biotherapeutics, Inc. | $8,473 1,211 shares | -2% | - | |
| 37Weak | Atara Biotherapeutics, Inc. | $15k 1,364 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2025 | ZURA Zura Bio Ltd | AGrant or award Employee Share Option (Right to Buy)derivative | +672,000 | $0.00 | $0 | 672,000 | Jul 17, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -1,900 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -460 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -496 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -154 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -381 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -350 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -262 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -543 | $0.00 | $0 | 160 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -331 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | ATRA Atara Biotherapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -8,961 | $0.00 | $0 | 2,656 | Apr 2, 2025 |
| Mar 3, 2025 | ATRA Atara Biotherapeutics, Inc. | SOpen-market sale Common Stock | -1,211 | $7.00 | $8,473 | 56,231 | Mar 5, 2025 |
| Jan 27, 2025 | ATRA Atara Biotherapeutics, Inc. | AGrant or award Common Stock | +34,050 | $0.00 | $0 | 57,442 | Jan 29, 2025 |
| Nov 18, 2024 | ATRA Atara Biotherapeutics, Inc. | SOpen-market sale Common Stock | -1,364 | $11.20 | $15k | 23,392 | Nov 20, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.